These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 29624154

  • 1. The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.
    Bashir A, Brennum J, Broholm H, Law I.
    J Neurosurg; 2018 Apr 06; 130(2):451-464. PubMed ID: 29624154
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma.
    Rapp M, Heinzel A, Galldiks N, Stoffels G, Felsberg J, Ewelt C, Sabel M, Steiger HJ, Reifenberger G, Beez T, Coenen HH, Floeth FW, Langen KJ.
    J Nucl Med; 2013 Feb 06; 54(2):229-35. PubMed ID: 23232275
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of 18F-FET PET and perfusion-weighted MRI for glioma grading: a hybrid PET/MR study.
    Verger A, Filss CP, Lohmann P, Stoffels G, Sabel M, Wittsack HJ, Kops ER, Galldiks N, Fink GR, Shah NJ, Langen KJ.
    Eur J Nucl Med Mol Imaging; 2017 Dec 06; 44(13):2257-2265. PubMed ID: 28831534
    [Abstract] [Full Text] [Related]

  • 8. Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans.
    Albert NL, Winkelmann I, Suchorska B, Wenter V, Schmid-Tannwald C, Mille E, Todica A, Brendel M, Tonn JC, Bartenstein P, la Fougère C.
    Eur J Nucl Med Mol Imaging; 2016 Jun 06; 43(6):1105-14. PubMed ID: 26666239
    [Abstract] [Full Text] [Related]

  • 9. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?
    Pöpperl G, Kreth FW, Herms J, Koch W, Mehrkens JH, Gildehaus FJ, Kretzschmar HA, Tonn JC, Tatsch K.
    J Nucl Med; 2006 Mar 06; 47(3):393-403. PubMed ID: 16513607
    [Abstract] [Full Text] [Related]

  • 10. Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET).
    Bashir A, Mathilde Jacobsen S, Mølby Henriksen O, Broholm H, Urup T, Grunnet K, Andrée Larsen V, Møller S, Skjøth-Rasmussen J, Skovgaard Poulsen H, Law I.
    Neuro Oncol; 2019 Dec 17; 21(12):1595-1606. PubMed ID: 31618420
    [Abstract] [Full Text] [Related]

  • 11. Potential for differentiation of glioma recurrence from radionecrosis using integrated 18F-fluoroethyl-L-tyrosine (FET) positron emission tomography/magnetic resonance imaging: A prospective evaluation.
    Sogani SK, Jena A, Taneja S, Gambhir A, Mishra AK, D'Souza MM, Verma SM, Hazari PP, Negi P, Jadhav GK.
    Neurol India; 2017 Dec 17; 65(2):293-301. PubMed ID: 28290392
    [Abstract] [Full Text] [Related]

  • 12. Textural analysis of pre-therapeutic [18F]-FET-PET and its correlation with tumor grade and patient survival in high-grade gliomas.
    Pyka T, Gempt J, Hiob D, Ringel F, Schlegel J, Bette S, Wester HJ, Meyer B, Förster S.
    Eur J Nucl Med Mol Imaging; 2016 Jan 17; 43(1):133-141. PubMed ID: 26219871
    [Abstract] [Full Text] [Related]

  • 13. Voxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas.
    Blanc-Durand P, Van Der Gucht A, Verger A, Langen KJ, Dunet V, Bloch J, Brouland JP, Nicod-Lalonde M, Schaefer N, Prior JO.
    PLoS One; 2018 Jan 17; 13(6):e0199379. PubMed ID: 29953478
    [Abstract] [Full Text] [Related]

  • 14. O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy.
    Sweeney R, Polat B, Samnick S, Reiners C, Flentje M, Verburg FA.
    Ann Nucl Med; 2014 Feb 17; 28(2):154-62. PubMed ID: 24272067
    [Abstract] [Full Text] [Related]

  • 15. Glioma Recurrence Versus Radiation Necrosis: Single-Session Multiparametric Approach Using Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI.
    Jena A, Taneja S, Gambhir A, Mishra AK, Dʼsouza MM, Verma SM, Hazari PP, Negi P, Jhadav GK, Sogani SK.
    Clin Nucl Med; 2016 May 17; 41(5):e228-36. PubMed ID: 26859208
    [Abstract] [Full Text] [Related]

  • 16. Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.
    Galldiks N, Rapp M, Stoffels G, Fink GR, Shah NJ, Coenen HH, Sabel M, Langen KJ.
    Eur J Nucl Med Mol Imaging; 2013 Jan 17; 40(1):22-33. PubMed ID: 23053325
    [Abstract] [Full Text] [Related]

  • 17. Detection of recurrent high-grade glioma using microstructure characteristics of distinct metabolic compartments in a multimodal and integrative 18F-FET PET/fast-DKI approach.
    Lohmeier J, Radbruch H, Brenner W, Hamm B, Hansen B, Tietze A, Makowski MR.
    Eur Radiol; 2024 Apr 17; 34(4):2487-2499. PubMed ID: 37672058
    [Abstract] [Full Text] [Related]

  • 18. The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PET.
    Malkowski B, Harat M, Zyromska A, Wisniewski T, Harat A, Lopatto R, Furtak J.
    PLoS One; 2015 Apr 17; 10(10):e0140917. PubMed ID: 26468649
    [Abstract] [Full Text] [Related]

  • 19. The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.
    Galldiks N, Stoffels G, Filss C, Rapp M, Blau T, Tscherpel C, Ceccon G, Dunkl V, Weinzierl M, Stoffel M, Sabel M, Fink GR, Shah NJ, Langen KJ.
    Neuro Oncol; 2015 Sep 17; 17(9):1293-300. PubMed ID: 26008606
    [Abstract] [Full Text] [Related]

  • 20. The use of O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of gliomas located in the brainstem and spinal cord.
    Tscherpel C, Dunkl V, Ceccon G, Stoffels G, Judov N, Rapp M, Meyer PT, Kops ER, Ermert J, Fink GR, Shah NJ, Langen KJ, Galldiks N.
    Neuro Oncol; 2017 May 01; 19(5):710-718. PubMed ID: 28039366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.